ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Caplan: NEJM Should Go “The Extra Moral Mile”

January 9, 2009

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

AACR Honors Former President Bush

March 29, 2002

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

Doctor Files Defamation Suit Against Former Patient, But Legal Action Triggers Adverse Events

April 20, 2012

Environmental Carcinogenesis Seen As Next Big Growth Field; NCA Hears Problems, Priorities

October 31, 1975